Literature DB >> 20096732

Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice.

Santoshkumar Tota1, Himani Awasthi, Pradeep Kumar Kamat, Chandishwar Nath, Kashif Hanif.   

Abstract

The aim of the present study is to investigate the effect of quercetin, a naturally occurring flavonoid, on cerebral blood flow (CBF), brain energy metabolism, memory impairment, oxidative stress and cholinergic dysfunction in brain following intracerebral (i.c.) streptozotocin (STZ) administration in mice. STZ (0.5mg/kg, i.c.) was administered twice at an interval of 48h. We found a significant reduction in CBF as measured by Laser Doppler Flowmetry (LDF). The brain energy metabolism was also altered as evidenced by significant reduction in brain ATP content. Daily treatment with quercetin (2.5, 5 and 10mg/kg, p.o.) starting from the first dose of STZ showed a dose-dependent restoration of CBF and ATP content. Further, quercetin prevented STZ induced memory impairment as assessed by Morris water maze and passive avoidance tests. Biochemical analysis revealed that STZ significantly increased malondialdehyde (MDA), nitrite and depleted glutathione (GSH) levels in the mice brain. Quercetin decreased oxidative and nitrosative stress as evidenced by a significant decrease in MDA, nitrite and increase in GSH levels. Quercetin also attenuated elevated acetylcholinesterase activity in the STZ-treated mice. Neither STZ (i.c.) nor quercetin showed any change in locomotor activity and blood glucose level. The present study demonstrates the beneficial effects of quercetin in improving CBF along with preventing memory impairment, oxidative stress, altered brain energy metabolism and cholinergic dysfunction caused by STZ in mice. Therefore, consumption of dietary stuff rich in quercetin should be encouraged to ward off dementia associated with vascular and neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096732     DOI: 10.1016/j.bbr.2010.01.017

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  35 in total

Review 1.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Santosh Kumar Tota; Ashok Kumar; Abdullah S Ahmad
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

Review 2.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

3.  Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.

Authors:  Santoshkumar Tota; Kashif Hanif; Pradeep Kumar Kamat; Abul Kalam Najmi; Chandishwar Nath
Journal:  Psychopharmacology (Berl)       Date:  2012-02-24       Impact factor: 4.530

4.  Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats.

Authors:  Xia Zhu; Ya-Qin Cheng; Qian Lu; Lei Du; Xiao-Xing Yin; Yao-Wu Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

5.  Cadmium level in brain correlates with memory impairment in F1 and F2 generation mice: improvement with quercetin.

Authors:  Sumita Halder; Rajarshi Kar; Sucharita Chakraborty; Swapan K Bhattacharya; Pramod K Mediratta; Basu D Banerjee
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-07       Impact factor: 4.223

6.  Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence.

Authors:  Jogender Mehla; Monika Pahuja; Pooja Gupta; Shekhar Dethe; Amit Agarwal; Yogendra Kumar Gupta
Journal:  Psychopharmacology (Berl)       Date:  2013-07-06       Impact factor: 4.530

7.  Age-related changes in AMP-activated protein kinase after stroke.

Authors:  Fudong Liu; Sharon E Benashski; Rebecca Persky; Yan Xu; Jun Li; Louise D McCullough
Journal:  Age (Dordr)       Date:  2011-03-01

8.  Effect of silibinin on the pharmacokinetics of nitrendipine in rabbits.

Authors:  Swathi Voruganti; Shravan Kumar Yamsani; Madhusudan Rao Yamsani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-10-05       Impact factor: 2.441

Review 9.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

10.  Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats.

Authors:  Deep Raj Sharma; Willayat Yousuf Wani; Aditya Sunkaria; Ramesh J L Kandimalla; Deepika Verma; Swaranjit Singh Cameotra; Kiran Dip Gill
Journal:  Neurotox Res       Date:  2012-08-24       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.